Fresh Tracks Therapeutics Inc Investor Relations Material
Latest events
Q3 2022
Fresh Tracks Therapeutics Inc
Q4 2023
15 Mar, 2024
Q3 2023
13 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Fresh Tracks Therapeutics Inc
Access all reports
Fresh Tracks Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for autoimmune, inflammatory, and other skin-related diseases. The company's pipeline includes small molecule and biologic drug candidates designed to target the underlying causes of these conditions. Fresh Tracks aims to provide new treatment options that address unmet medical needs in dermatology and immunology. The company serves the healthcare sector, specifically focusing on skin health and immune system disorders. The company is headquartered in Boulder, Colorado, and its shares are listed on the NASDAQ.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
FRTX
Country
🇺🇸 United States